Showing results (1071-1080 of 1,252) with videos related to

Sort By:
Pageof 126
JAMA Network Open|March 17, 2023
Evaluation of the Emergency Severity Index in US Emergency Departments for the Rate of MistriageDana R Sax, E Margaret Warton, Dustin G Mark, et al.
AIDS Research and Therapy|April 8, 2025
Long-term metabolic changes with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir-containing regimens for HIVEric S Daar, Chloe Orkin, Paul E Sax, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|March 5, 2020
Endplate volumetric bone mineral density measured by quantitative computed tomography as a novel predictive measure of severe cage subsidence after standalone lateral lumbar fusionIchiro Okano, Conor Jones, Stephan N Salzmann, et al.
RSC Chemical Biology|February 7, 2022
Inhibition of SC4MOL and HSD17B7 shifts cellular sterol composition and promotes oligodendrocyte formationMatthew J Pleshinger, Ryan M Friedrich, Zita Hubler, et al.
The Lancet. HIV|November 20, 2019
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trialJean-Michel Molina, Kathleen Squires, Paul E Sax, et al.
Open Forum Infectious Diseases|March 22, 2019
No Significant Changes to Residual Viremia After Switch to Dolutegravir and Lamivudine in a Randomized TrialJonathan Z Li, Paul E Sax, Vincent C Marconi, et al.
AIDS Patient Care and Stds|June 5, 2026
People with HIV Continuing on Complex Regimens in the Era of Treatment Optimization: Characteristics and OutcomesPaul E Sax, Keith J Dunn, Janna Radtchenko, et al.
Plos One|February 14, 2020
Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCVSonia Vibhakar Patel, Dushyantha T Jayaweera, Keri N Althoff, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|March 2, 2005
Steel dust in the New York City subway system as a source of manganese, chromium, and iron exposures for transit workersSteven N Chillrud, David Grass, James M Ross, et al.
Infection & Chemotherapy|October 6, 2016
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian Subjects with Human Immunodeficiency Virus 1 Infection: A Sub-Analysis of Phase 3 Clinical TrialsJun Yong Choi, Somnuek Sungkanuparph, Thanomsak Anekthananon, et al.
Pageof 126